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Functional neurosurgerya b s t r a c t
Background: ‘‘Selective peripheral neurotomies” (SPNs) are indicated for the treatment of refractory focal
and multifocal spasticity of lower limbs in adults.
Objective: To evaluate the surgical results of selective peripheral neurotomies in 20 adult patients who
had refractory focal & multifocal spasticity of the lower limbs, follow up period of one year.
Patients and Methods: Prospective study included 20 adult patients who had refractory spasticity of the
lower limbs. Preoperative evaluation for muscle tone using Modified Ashworth Score (MAS), muscle
power using Medical Research Council Scale (MRCS), functional assessment using Oswestry Functional
Scale (OFS) and Range Of Motion (ROM) using manual goniometry were done for all patients. All cases
underwent surgery in the form of SPN of tibial, obturator, sciatic and/or femoral nerves. Follow up of
the patients was done at 10th day, 3, 6 months and one year postoperatively.
Results: The mean age of patients was 31.35 ± 12.42 years. There were statistically significant improve-
ment of muscle tone, muscle power, functional assessment and range of motion between preoperative
and one year postoperative values. Improvement of the muscle tone was from a preoperative
Mean ± SD of 3.60 ± 0.68 on MAS to a postoperative 2.30 ± 0.86 at one year, improvement of muscle
power on MRCS was from preoperative Mean ± SD 3.75 ± 1.08 to postoperative 4.08 ± 0.69 at one year,
There was a functional improvement from a preoperative Mean ± SD of 3.0 ± 0.73 on OFS to 3.60 ± 0.60
at one year postoperatively. Also, there was a significant improvement between preoperative ROM
Mean ± SD 61.25 ± 15.29 and one year postoperatively 72.25 ± 12.19.
Conclusions: Selective peripheral neurotomies could effectively improve muscle tone, muscle power,
functional performance & range of motion in patients with refractory focal and multifocal spasticity in
the lower limbs.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Peripheral neurotomies (PNs) are old neurosurgical techniques
that were introduced hundred years ago. Recently, the develop-
ment of microsurgical techniques and electrophysiological moni-
toring lead to the reintroduction of PNs. PNs are dedicated for
severe focal and multifocal spasticity, when injection of botulinum
toxin becomes ineffective and surgery cannot be delayed any
more.1–3Peripheral neurotomies aim at restoring the balance between
the muscle tone of agonist and antagonist muscles by lowering
excessive spasticity. Spasticity is decreased in PNs by sectioning
the efferent motor fibers of the stretch reflex of the nerve supply-
ing the target muscle.3
Surgery should be done so that the increased hypertonia is min-
imized without a drop of the useful muscle tone or loss of the
motor and sensory residual functions. PNs can be done ‘‘selec-
tively” by microsurgical dissection of the motor fascicles and their
monitoring using intra-operative electrical nerve stimulation.3–8
Neurotomy consists of sectioning part of one or several motor
fascicles of the nerves innervating the target muscle(s), in which
spasticity is excessive. Motor branches should be targeted where
they are isolated from the nerve trunk or they can be dissected
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ing a known branch.8
There is no standardized basis for the extent of the partial sec-
tion. However, most experienced spasticity surgeons agree that
motor fascicles sectioning must include 50–80% (usually 75%) of
the fibers supplying a targeted muscle. Before doing any PN, nerve
block test of the motor nerves innervating the target muscles is
recommended.7,92. Aim of the work
The aim of this work was to evaluate the surgical results of
‘‘selective peripheral neurotomies” of tibial, obturator, sciatic
and/or femoral nerves in 20 adult patients who had refractory focal
and multifocal spasticity of the lower limbs.3. Patients and methods
This was a prospective study which included 20 patients who
had refractory focal or multifocal spasticity of the lower limbs.
The study was done in the ‘‘Department of Neurosurgery, Ain-
Shams University Hospitals, Cairo, Egypt” in the period between
November 2014 and November 2016. Ethics committee approval
for the study design and statistical methodology was obtained.3.1. Inclusion criteria
Age > 18 years old.
Focal or multifocal spasticity refractory to optimal pharmaco-
logical andnor physical therapy.
Positive anesthetic nerve block test.Table 1
Distribution of different etiologies of spasticity in this study.








Hereditary spastic paraplegia 23.2. Exclusion criteria
Negative anesthetic nerve block test.
Contraindication to surgery andnor anesthesia.
Selection and assessment of patients were performed carefully
by assessment of muscle tone by ‘‘Modified Ashworth Score”
(MAS),10 motor power function using ‘‘Medical Research Council
Scale” (MRCS),11 function assessment by ‘‘Oswestry Function Scale”
(OFS)12 and range of motion (ROM) assessment by manual
goniometry.
Assessment of MAS, MRCS and ROM were performed only for
muscle groups involved in harmful spasticity (muscle groups that
underwent neurosurgical intervention) and the mean of the scores
were used for pre and post- operative statistical evaluation. For
statistical analysis purposes, the grade of 1+ on the MAS was con-
sidered a 2, and 1 was added to the remaining grades, so the grades
ranged from 0 to 5.
Visual gait analysis and videotaping were done for all selected
patients with focal and multifocal lower limb spasticity to aid in
differentiating harmful spasticity from functionally useful spastic-
ity. Nerve blocks with 3 ml of 0.25% xylocaine were used for pre-
dicting the outcome of peripheral neurotomy insuring patients’
satisfaction.
All surgeries were performed under general anesthesia and
without long-acting muscle relaxants so that the motor responses
elicited by nerve stimulation of motor branches could be detected.
Microsurgical resection of at least 50% of the targeted motor
branches was performed. The surgical planning was taken in a
multidisciplinary approach for each patient, depending on the
degree of preoperative spasticity, the functional performance,
and the presence of muscle or bony deformities.Tibial neurotomy was indicated for spastic foot deformity, sci-
atic neurotomy for hamstring hypertonia, obturator neurotomy
for adductor spasm, and femoral neurotomy for hypertonic quadri-
ceps femoris.13,14
Post-operative evaluation visits were scheduled at the 10th day,
3rd month, 6th month and one year; evaluation measures were
recorded for each patient for statistical comparison with the pre-
operative measurements.
3.3. Statistical analysis
Data were fed to the computer and analyzed using IBM SPSS
software package version 20.0. (Armonk, NY: IBM Corp). Qualita-
tive data were described using number and percent. The
Kolmogorov-Smirnov test was used to verify the normality of dis-
tribution Quantitative data were described using range (minimum
and maximum), mean, standard deviation and median. Signifi-
cance of the obtained results was judged at the 5% level. We used
Wilcoxon signed ranks test for abnormally distributed quantitative
variables, to compare between two periods.15,16
4. Results
Twenty patients were included in this study; 13 males (65%),
the mean age was 31.35 ± 12.42 years. Eleven patients (55%) had
paraparesis, seven patients (35%) had hemiparesis, and two
patients (10%) had quadriparesis. Different etiologies of spasticity
in this study were described in (Table 1).
A total of 60 selective peripheral neurotomies were performed:
28 were tibial, 15 were obturator, 15 were sciatic, and 2 were
femoral neurotomies. Multiple level neurotomies were done as a
single staged surgery.
Orthopedic surgeries for muscle contracture were done simul-
taneously with neurotomies in six patients (30%).
4.1. Muscle tone
There was a marked reduction of the muscle tone from a preop-
erative mean MAS of 3.60 ± 0.68 to a postoperative score of
2.25 ± 0.79 at the 10th day, 3 months, 6 months and 2.30 ± 0.86
at one year postoperatively (p < 0.001) (Table 2 and Fig. 1).
4.2. Muscle power
There was no statistically significant difference between preop-
erative evaluation and the 6th month follow up assessment
(p = 0.066). However, there was a statistically significant change
at the one year follow up assessment (p = 0.041) (Table 3).
Five patients (25%) showed improvement on MRCS. However, a
decrease of 1–2 grades in muscle power by MRCS in the operated
limb was found in almost all patients in the early post-operative
period. This may be related either to surgical manipulations of
the nerves or to the pre-existing weakness (due to UMNL) became
Table 2
The change in the muscle tone (MAS) through the study period.
Pre-operative Post-operative
10th day 3 Months 6 Months 1 Year
MAS
Mean ± SD 3.60 ± 0.68 2.25 ± 0.79 2.25 ± 0.79 2.25 ± 0.79 2.30 ± 0.86
p <0.001* <0.001*
p: p value for Wilcoxon signed ranks test comparing between pre-operative with each of 6 months and 1 year.
* Statistically significant at p  0.05.
Fig. 1. The change in the mean MAS through the study period.
Table 3
The change in the muscle power according to MRCS through the study period.
Pre-operative Post-operative
10th day 3 Months 6 Months 1 Year
MRCS
Mean ± SD 3.75 ± 1.08 3.78 ± 0.98 3.93 ± 0.73 4.03 ± 0.66 4.08 ± 0.69
p 0.066 0.041*
p: p value for Wilcoxon signed ranks test comparing between pre-operative with each of 6 months and 1 year.
* Statistically significant at p  0.05.
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control then improved later, especially after regular rehabilitation.
4.3. Range of motion
There was a statistically significant change in the joints ROM at
the 6th months and the one year follow up assessment (p < 0.001)
(Table 4).Table 4




Mean ± SD. 61.25 ± 15.29 70.75 ± 13.31
p
p: p value for Wilcoxon signed ranks test comparing between pre-operative with each o
* Statistically significant at p  0.05.4.4. Functional assessment
The changes in the mean OFS was significant at the 6th month
and one year evaluation visits (p < 0.001). Twelve patients (60%)
showed functional improvement of 1 grade on OFS by the end of
the first year post-operatively, while the remaining eight patients
(40%) did not show any functional improvement (Table 5).3 Months 6 Months 1 Year
72.50 ± 12.19 73.0 ± 11.85 72.25 ± 12.19
<0.001* <0.001*
f 6 months and 1 year.
Table 5
The change in the Oswestry Functional Scale through the study period.
Pre-operative Post-operative
10th day 3 Months 6 Months 1 Year
Oswestry functional scale
Mean ± SD. 3.0 ± 0.73 3.50 ± 0.61 3.55 ± 0.60 3.60 ± 0.60 3.60 ± 0.60
p 0.001* 0.001*
p: p value for Wilcoxon signed ranks test comparing between pre-operative with each of 6 months and 1 year.
* Statistically significant at p  0.05.
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Two patients who were subjected to selective tibial neuro-
tomies had paresthesias of the lateral aspect of the leg and foot.
Gabapentin was prescribed for both of them and they showed
improvement of symptoms by the 3rd month post-operative eval-
uation visit.5. Discussion
Spasticity is referred to increased tone of the muscle due to
hyper-excitable stretch reflex. This hyperactive spinal reflex is
the result of the loss of inhibitory signals from the descending
supraspinal control. It is a component of the upper motor neuron
syndrome and may be associated with muscle weakness and
absence of selective motor control.13
Treatment of spasticity is not indicated just for the presence of
stiffness because sometimes spasticity is helpful to the patient to
maintain balance and to compensate for muscle weakness. Taking
this in mind, spasticity should only be treated when hypertonia
leads to more functional losses, reducing locomotion, enhancing
deformities, or causing pain (i.e. harmful spasticity).13
The technological advances in microsurgical techniques have
made PN more selective by finely dissecting the fascicles using
microsurgery and by using intra-operative electrical stimulation
for mapping to better identify the function of the individual nerve
fascicles.7–9
In this study, SPNs were performed for 20 adult patients with
refractory lower limb spasticity. Almost all patients showed
improvement post operatively in the10th day which continued
all through the follow up period of one year.
In agreement with our study, Rousseaux et al.17 reported a last-
ing drop in spasticity (2.5 points on the MAS).
In the current study, the muscle tone showed a statistically sig-
nificant decrease on MAS which unmasked underlying motor
power in about 25% of patients. This explains how removing the
harmful spasticity can allow the muscle to function better with
improvement of the active movements and of gait and balance in
ambulatory patients. The discomfort caused by spasticity is
relieved too.
In this study, there were two patients (10%) suffering from tran-
sient paresthesias following tibial neurotomy which may be due to
potential damage to the sural nerve. This result was in agreement
with Buffenoir et al.18, who reported that 5.45% of his patients
developed transient paresthesias.
After tone lowering by neurosurgical interventions for spastic-
ity, some patients may have residual fixed muscle contractures
or bony deformities that, if not corrected at the same time of neu-
rotomy, should be fixed in another session.
Improvement in MRCS and OFS are more evident at 6 months
and 1 year follow-up visits. This result was in accordance with
Fouad19 who stated that the outcome of PN also intimately
depends on the postoperative care after a successful surgery and
physical therapy beginning on the second postoperative day. Sorapidly the patient should undergo a program of physical and occu-
pational therapy for at least six months.
6. Limitations of the study
The number of patients included in this study is too small for
comparing cerebral and spinal origin spasticity. So, we need fur-
ther research to address the difference in outcome of ‘‘selective
peripheral neurotomy” between spasticity of cerebral origin and
spasticity of spinal origin.
7. Conclusions
Amultidisciplinary program for the treatment of disabling spas-
ticity resistant to physical and medical therapy has to be tailored to
the individual problems of each patient to avoid insufficient sur-
gery or the loss of motor power in the target muscles.
Selective peripheral neurotomies could effectively improve
muscle tone, power, range of motion & functional performance in
adult patients with refractory focal or multifocal spasticity of the
lower limbs. Multilevel ‘‘selective peripheral neurotomies” can be
combined for the treatment of one patient in one staged surgery.References
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